Abstract
Monocytes originate from progenitors in bone marrow and circulate through blood vessels and patrol the vascular endothelium or differentiate into mononuclear phagocytes and infiltrate via the bloodstream to peripheral tissues during infection and other inflammatory conditions. Recruitment of inflammatory monocytes is essential for effectively clearance of bacteria, control of Toxoplasma gondii infections and limiting tissue damage. Unexpectedly, Ly6Chi inflammatory monocytes acquire the inflammatory regulatory capacity dual phenotypes during acute infection and inflammation. In addition, inflammatory monocytes can be recruited to tumor sites and inhibit tumor-specific immune defense. Here, we explored the recruitment and characteristics of Ly6Chi inflammatory monocytes and their immune regulatory function in acute inflammation, infection and tumor models. We also contrasted the differences between M2 macrophages and Ly6Chi inflammatory monocytes and, in particular, compared the shared common characteristics between these immune cell types. The Ly6Chi inflammatory monocyte regulatory functions in infectious and inflammatory conditions are the focus of this review.
Keywords: Monocyte differentiation, monocyte subsets, chemokine receptors, regulatory monocytes, inflammation regulatory.
Current Molecular Medicine
Title:The Immune Function of Ly6Chi Inflammatory Monocytes During Infection and Inflammation
Volume: 17 Issue: 1
Author(s): L. Liu, Y. Wei and X. Wei*
Affiliation:
- Laboratory for Aging Research, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu 610041,China
Keywords: Monocyte differentiation, monocyte subsets, chemokine receptors, regulatory monocytes, inflammation regulatory.
Abstract: Monocytes originate from progenitors in bone marrow and circulate through blood vessels and patrol the vascular endothelium or differentiate into mononuclear phagocytes and infiltrate via the bloodstream to peripheral tissues during infection and other inflammatory conditions. Recruitment of inflammatory monocytes is essential for effectively clearance of bacteria, control of Toxoplasma gondii infections and limiting tissue damage. Unexpectedly, Ly6Chi inflammatory monocytes acquire the inflammatory regulatory capacity dual phenotypes during acute infection and inflammation. In addition, inflammatory monocytes can be recruited to tumor sites and inhibit tumor-specific immune defense. Here, we explored the recruitment and characteristics of Ly6Chi inflammatory monocytes and their immune regulatory function in acute inflammation, infection and tumor models. We also contrasted the differences between M2 macrophages and Ly6Chi inflammatory monocytes and, in particular, compared the shared common characteristics between these immune cell types. The Ly6Chi inflammatory monocyte regulatory functions in infectious and inflammatory conditions are the focus of this review.
Export Options
About this article
Cite this article as:
Liu L., Wei Y. and Wei X.*, The Immune Function of Ly6Chi Inflammatory Monocytes During Infection and Inflammation, Current Molecular Medicine 2017; 17 (1) . https://dx.doi.org/10.2174/1566524017666170220102732
DOI https://dx.doi.org/10.2174/1566524017666170220102732 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Heme Oxygenase Overexpression Attenuates Glucose-Mediated Oxidative Stress in Quiescent Cell Phase: Linking Heme to Hyperglycemia Complications
Current Neurovascular Research New Psychoactive Substances 3-Methoxyphencyclidine (3-MeO-PCP) and 3-Methoxyrolicyclidine (3-MeO-PCPy): Metabolic Fate Elucidated with Rat Urine and Human Liver Preparations and their Detectability in Urine by GC-MS, “LC-(High Resolution)-MSn” and “LC-(High Resolution)-MS/MS”
Current Neuropharmacology Have We New Therapeutic Strategies in the Treatment of Renovascular Nephropathy?
Current Vascular Pharmacology Patent Annotations
Recent Patents on Anti-Infective Drug Discovery Asymmetric Dimethylarginine: Clinical Significance and Novel Therapeutic Approaches
Current Medicinal Chemistry ES-MDA: Enhanced Similarity-based MiRNA-Disease Association
Current Protein & Peptide Science Clinical and Forensic Signs Related to Opioids Abuse
Current Drug Abuse Reviews Protein-Protein Interactions in Drug Discovery
Drug Design Reviews - Online (Discontinued) COVID-19 Related Coagulopathy: What is Known Up to Now
Current Medicinal Chemistry Potential Health Benefits of Berries
Current Nutrition & Food Science Editorial: Lipoprotein (a), More than Just Cholesterol?
Current Medicinal Chemistry Therapeutic Use of Antioxidants in Sepsis
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Mn-SOD and Chronic Inflammation of Gastric Mucosa
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Schizophrenia: Causes and Treatments
Current Pharmaceutical Design Recent Advances in Natural Product-Based Anti-Biofilm Approaches to Control Infections
Mini-Reviews in Medicinal Chemistry Probiotics as an Alternative Strategy for Prevention and Treatment of Human Diseases: A Review
Inflammation & Allergy - Drug Targets (Discontinued) Evaluation of In Vivo and In Vitro Antimicrobial Activities of a Selective Serotonin Reuptake Inhibitor Sertraline Hydrochloride
Anti-Infective Agents Stem Cell Aging and Age-Related Cardiovascular Disease: Perspectives of Treatment by Ex-vivo Stem Cell Rejuvenation
Current Drug Targets Chinese Medicine in Inhalation Therapy: A Review of Clinical Application and Formulation Development
Current Pharmaceutical Design Cerebrovascular Complications of Diabetes: SGLT-2 Inhibitors as a Promising Future Therapeutics
Current Drug Targets